Related Experiment Video
Updated: Apr 8, 2026

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
Published on: February 7, 2025
Delirium in Children Hospitalized with Acute COVID-19 or MIS-C: Secondary Analysis of the 2020-2021 Global Consortium
Neelima K Marupudi1, Diana Paola Escobar Serna2,3, Leslie Dervan4
1Department of Child Health, University of Arizona, Banner Children's Hospital at Desert, 1400 S. Dobson Rd., Mesa, AZ, 85202, USA. Neelima.Marupudi@Bannerhealth.com.
Insights
Pediatric delirium in hospitalized children with COVID-19 or MIS-C was linked to inflammation and severe neurological issues. Early screening for delirium is crucial for better outcomes in these children.
Area of Science:
- Pediatric critical care medicine
- Infectious diseases
- Neurology
Background:
- Pediatric delirium is a significant concern in hospitalized children.
- Understanding delirium's associations in COVID-19 and MIS-C is crucial.
Purpose of the Study:
- To describe pediatric delirium.
- To investigate its association with inflammatory markers, neurodiagnostic findings, and clinical severity in children with acute COVID-19 or MIS-C.
Main Methods:
- Secondary analysis of a multicenter, prospective observational cohort study.
- Included hospitalized children (<18 years) with confirmed acute COVID-19 or MIS-C.
- Data collected from January 2020 to July 2021 across 46 hospitals globally.
Main Results:
- Delirium occurred in 1.8% of 3211 patients, more frequently in MIS-C (3.6%) than COVID-19 (1.5%).
- Delirious children had higher inflammatory markers, severe neurological manifestations, and abnormal EEG findings.
- Delirium was associated with longer hospital stays, higher mortality, and worse functional outcomes (PCPC, FSS).
Conclusions:
- Pediatric delirium in SARS-CoV-2-related illness correlates with systemic inflammation, neurological injury, and adverse clinical outcomes.
- Routine delirium screening and intervention are vital for children hospitalized with SARS-CoV-2 infections and other inflammatory conditions.
Background/Objective:
The aims of this study were to describe pediatric delirium and its association with inflammatory, neurodiagnostic, and clinical severity profiles in children hospitalized with acute coronavirus disease 2019 (COVID-19) infection or multisystem inflammatory syndrome in children (MIS-C).
Methods:
We performed a secondary analysis of a multicenter, prospective observational cohort study including hospitalized children (< 18 years) with confirmed acute COVID-19 infection or MIS-C enrolled between 1 January 2020 and 31 July 2021 at 46 hospitals across ten countries participating in the Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-NeuroCOVID).
Results:
Among 3211 patients, 57 (1.8%) had documented delirium. Delirium was more common in MIS-C than in acute COVID-19 (3.6% vs. 1.5%, p = 0.004). Children with delirium had higher inflammatory markers (e.g., C-reactive protein, ferritin, D-dimer, procalcitonin) and more frequently presented with severe neurologic manifestations (all p < 0.001). Patients with delirium underwent more neurodiagnostic testing (p < 0.001). Among children with delirium who received electroencephalogram (EEG) testing, abnormalities were universal (n = 23). Delirium was associated with longer hospital stays (median 17 vs. 4 days; p < 0.001), higher mortality (7.5% vs. 1.1%; p = 0.01), and worse functional outcomes, including higher rates of new disability at discharge as assessed by Pediatric Cerebral Performance Category (PCPC; 22.5% vs. 1.7%, p < 0.001) and functional status scale (FSS; 22.7% vs. 2.1%, p = 0.001).
Conclusions:
Delirium in a select group of patients with pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related illness was associated with systemic inflammation, severe neurologic injury, and worse clinical outcomes in a multicenter cohort. These findings underscore the importance of routine delirium screening and intervention in children hospitalized with SARS-CoV-2-related illnesses and other inflammatory conditions.
Related Concept Videos
Viral Meningitis
Acute Kidney Injury III: Clinical Manifestations
Acute Respiratory Failure-IV